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Introduction 
Hypertension is a serious and common condition that is prevalent in both developing and 
economically stable countries (Vogt et al., 1999). It increases a patient’s risk for cardiovascular 
disease including myocardial infarction, stoke, and end stage renal disease (Vogt et al., 1999). 
The use of medical nutrition therapy to treat hypertension focuses on specific life-style changes 
that have been proven to reduce blood pressure leading to a decrease in mortality and morbidity. 
This paper describes the importance of medical nutrition therapy in the reduction and treatment 
of hypertension and demonstrates the nutrition care process for hypertension using a case study 
patient.  
Hypertension 
Hypertension is the chronic elevation of blood pressure. Blood pressure is measured in 
terms of systolic pressure and diastolic pressure. According to the American Heart Association 
[AHA] (2020), systolic blood pressure is the pressure the heart exerts against the arterial wall 
when the heart beats. Diastolic blood pressure is the pressure the heart exerts against the arterial 
wall when the heart is resting (AHA, 2020). When reading a blood pressure measurement, 
systolic pressure is the first and often larger number followed by the diastolic pressure (AHA, 
2020). For example, a blood pressure reading of 120/80 indicates a systolic pressure of 120 and a 
diastolic pressure of 80.  
 In a clinical setting hypertension is organized into four levels, normal, elevated, stage 1 
and stage 2 (American College of Cardiology, 2017). Below, table1 indicates the blood pressure 
measurements for each stage.  
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There are two separate types of hypertension, primary, also known as essential, and 
secondary. Primary hypertension has no known causes (Nelms & Sucher, 2016). Secondary 
hypertension, however, is caused from other disorders such as kidney disease, heart disease, and 
disorders of the endocrine system (Mayo Clinic, 2020).  Primary hypertension is the most 
common type of hypertension and is usually related to lifestyle factors such as high sodium 
intake, low potassium intake, obesity, low activity levels, and/or genetics (Nelms & Sucher, 
2016). Additionally, there is a possibility for hypertension to respond poorly to medications 
which is known as resistant hypertension. Resistant hypertension is defined as stage 2 (>140/90 
mmHg) hypertension that is not normalized even after treatment with three to four 
antihypertensive medications (Sheppard, et al., 2017). The treatment for resistant hypertension 
typically includes the addition of four or more medications to normalize blood pressure 
(Sheppard, et al., 2017). The treatment goals for hypertension are to reduce blood pressure and 
reduce patient’s risk for the common comorbidities associated with hypertension through 
pharmacologic interventions and medical nutrition therapy (Nelms & Sucher, 2016).  
Pathophysiology 
Introduction  
Hypertension Levels Systolic Pressure  
(mm of Hg)  
 Diastolic pressure  
(mm of Hg) 
Normal  <120 And  <80  
Elevated  120-129 And  >80  
Stage 1 130-139 Or  80-89 
Stage 2  ≥140 And/ Or  ≥90 
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Elevated blood pressure is the result of an increase in cardiac output or an increase in 
peripheral vascular resistance or a combination of the two (Mayet & Hughes, 2003). Blood 
pressure regulation is controlled by several systems within the body including the autonomic and 
sympathetic nervous systems, the renin-angiotensin system, and the endocrine system. Defects 
from any one of these systems can lead to an increase in systemic vascular resistance and/or an 
increase in cardiac output leading to an increase in blood pressure (Beevers, et al, 2001). 
Additionally, research found an increase in blood pressure can be caused by insulin resistance, 
obesity, and high salt intake (Beevers, et al, 2001). The pathophysiology of hypertension greatly 
differs patient to patient. The following will review basic information regarding the 
pathophysiology of hypertension related to the autonomic nervous system, endocrine system, and 
the renin-angiotensin system.  
Autonomic nervous system  
Within the autonomic nervous system, the two branches of the system, parasympathetic 
and sympathetic, work together to regulate blood pressure. When stimulated, the sympathetic 
nervous system increases blood pressure using the neurotransmitters norepinephrine and 
epinephrine (Grassi & Mancia, 2014). The parasympathetic nervous system regulates the 
increase of blood pressure through neurotransmitter acetylcholine which slows down the heart 
rate. Hypertension has been shown to be related to an impairment of the parasympathetic system 
and an overdrive of the sympathetic system, which causes an increase on norepinephrine (Grassi, 
2015).  
Endocrine system  
Although epinephrine and norepinephrine are controlled by the autonomic nervous 
system, they are released by the adrenal glands, part of the endocrine system. Endocrine 
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disorders that result in an excessive release of epinephrine and norepinephrine can result in 
hypertension (Nelms & Sucher, 2016). Furthermore, it has been found that patients with 
hypertension have an increased sensitivity and release of norepinephrine (Mayet & Hughes, 
2003; Foex & Sear 2004).   
Renin-angiotensin system  
The renin-angiotensin system regulates blood pressure through the release of many 
different hormones. Renin is released from the granular cell in the kidney in response to 
sympathetic stimulation, reduced sodium-chloride and a decrease in blood flow to the kidney. 
Renin is used to convert angiotensin to angiotensin I which is then converted to angiotensin- 
converting enzyme (ACE) (Nelms & Sucher, 2016). ACE indirectly causes vasoconstriction 
through the breakdown of bradykinin, which is a vasodilator and ACE converts angiotensin I 
into angiotensin II (Beevers, 2001). Angiotensin II is a vasoconstrictor and will cause a rise in 
blood pressure (Beevers, 2001). Angiotensin II triggers aldosterone to be release from the 
adrenal cortex (Nelms & Sucher, 2016). The release of aldosterone also causes a rise in blood 
pressure by influencing the kidney to retain sodium which will increases blood volume (Nelms & 
Sucher, 2016).  
The renin-angiotensin system works in a negative feedback loop (Foex & Sear, 2004). 
When the renin-angiotensin system is operating correctly, high salt intake will cause a decrease 
in angiotensin II, thus decreasing the need for sodium retention (Drenjančević-Perić et al., 2011). 
In 40-50% of patients with primary hypertension, the mechanisms in which angiotensin II is 
controlled does not react to an increase in sodium intake (Drenjančević-Perić et al., 2011). In 
some incidences of hypertension, this phenomenon is caused by a salt sensitivity. In patients with 
a salt sensitivity, changes in blood pressure has a positive correlation with salt intake. For 
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example, an increase in salt intake raises blood pressure and a decrease in salt lowers blood 
pressure (Drenjančević-Perić et al., 2011). Salt sensitivities are common in individuals with renal 
disease, diabetes, obesity, hypertension, and old age (Drenjančević-Perić et al., 2011).  
Symptoms 
Hypertension typically does not present with symptoms, however, the symptoms can  
occur in some patients, such as shortness of breath, nose bleeds, and headaches (Mayo Clinic, 
2020). However, even though high blood pressure does not cause any specific symptoms, 
uncontrolled hypertension can lead to many health risks such as heart attacks and strokes (Mayo 
Clinic, 2020). Fortunately, because checking a patient’s blood pressure is part of routine 
assessments, hypertension can be easily caught by physicians (Mayo Clinic, 2020).   
Etiology 
Hypertension is associated with many risk factors that are both controllable and fixed. A 
few examples of controllable risks factors are smoking, poor diet, inactivity, obesity, diabetes 
mellitus and hyperlipidemia, and a few examples of fixed risk factors are chronic kidney disease, 
family history, and increased age (Whelton et al., 2018). The prevalence of hypertension 
increases from 6.8% to 11% in 20 to 34-year-olds, and to 78% in populations 75 years and older 
(Nelms, M., Sucher, K., 2016). Additional fixed risk factors include, gender, low socioeconomic 
status, obstructive sleep apnea, and psychosocial stress (Whelton et al., 2018). Diabetes is also a 
very common risk factor for hypertension. Seventy-one percent of adults in the Unites States 
who have been diagnosed with diabetes also are diagnosed with hypertension (Whelton et al., 
2018).  Hypertension is also related to the overactivation of the renin-angiotensin-aldosterone 
system (Whelton et al., 2018). Race is also a risk factor for hypertension where black populations 
have the highest prevalence at 40.3% for men and 42.9% for females (Nelms, M., Sucher, K., 
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2016) The second highest prevalence of hypertension is within the white population at 30.4% for 
men and 27.6% for females (Nelms, M., Sucher, K., 2016).  
Epidemiology: 
Hypertension is also known as the silent killer. This is because it often has no symptoms 
and goes is under diagnosed. According to the Center for Disease Control (2020), half of all 
adults in the United States have hypertension, however, only 1 in 4 of those adults have their 
hypertension under control. In 2018, hypertension was associated with approximately 500,000 
deaths. (Center for Disease Control, 2020). Additionally, there is an estimated cost of $46 billion 
in health care cost in 2009, both directly and indirectly related to hypertension (Nelms, M., 
Sucher, K., 2016). 
Nutrition Care Process 
 The nutrition care process includes, nutrition assessment, nutrition diagnosis, nutrition 
intervention, and nutrition monitoring and evaluation (Nelms & Sucher, 2016). The nutrition 
care process related to hypertension includes medical nutrition therapy interventions related to 
lifestyle modifications (Nelms & Sucher, 2016). According to the Evidence Analysis Library for 
the Academy of Nutrition and Dietetics, the current nutrition practice guidelines for the 
management of hypertension focus on medical nutrition therapy (MNT), vitamin D, potassium, 
calcium, magnesium, sodium, the Dietary Approaches to Stop Hypertension (DASH) dietary 
pattern, alcohol, and physical activity (Lennon, et al., 2017).  
The DASH diet is high in fruits, vegetables, and whole grains, while limiting fats intake and 
high in potassium, calcium, magnesium, and fiber (AND, 2020). To provide additional benefits it 
is recommended to limit sodium levels to between 1,500-2,400 mg per day in patient with 
hypertension (AND, 2020). Research has shown that when compared to the typical American 
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diet, following the DASH diet can decrease systolic blood pressure by 5-6 mmHg and diastolic 
blood pressure by 3 mmHg (Lennon et al., 2017). Patients with hypertension are recommended 
to meet the dietary reference intake (DRI) for calcium, magnesium, potassium, and vitamin D. In 
patients who are not able to meet the DRIs for these nutrients, supplementation has been found to 
improve blood pressure (Lennon et al, 2017). Weight loss is usually another important aspect to 
the treatment of hypertension. Counseling patients on a calorie-controlled DASH diet has been 
shown to reduce systolic blood pressure by 2 to 11 mmHg and diastolic blood pressure by 0 to 9 
mmHg. Additionally, engaging in 150-300 minutes of moderate to vigorous physical activity can 
lower systolic pressure 4-9 mmHg (Nelms & Sucher, 2016). However, even increasing physical 
activity to at least 30 minutes per day is shown to have a positive impact on lowering blood 
pressure (Nelms & Sucher, 2016). Smoking cessation is considered the most important lifestyle 
change an individual can do to reduce the risk of hypertension (Nelms & Sucher, 2016).  
Nutrition Assessment 
 A nutrition assessment is an important part of the nutrition care process. Information 
gathered during a nutrition assessment by a registered dietitian nutritionist (RDN) sets the 
foundation for the rest of the nutrition care process (Nelms & Sucher, 2016). A nutrition 
assessment aids the RDN in identifying nutrition related problems, creating a nutrition 
intervention, and successfully monitoring and evaluating the patient’s progress (Nelms & 
Sucher, 2016). During the assessment, the RDN focuses on dietary factors and patterns that are 
commonly associated with hypertension (Nelms, M., Sucher, K., 2016). The following nutrition 
assessment was conducted on patient X, including patient history, anthropometric data, 
biochemical data, nutrition focused physical exam, and food and nutrient related history.   
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Patient History  
 Patient history includes both the patient’s medical history and social history. Social 
factors such as socioeconomic status, education level, support systems, lifestyle, knowledge, and 
beliefs and attitudes are important to gather during a nutrition assessment (Nelms, M., Sucher, 
K., 2016). RDNs must consider social factors when planning and implementing a nutrition 
intervention. These factors play a large role in nutrition status and can affect the patient’s 
compliance with a nutrition intervention (Nelms, M., Sucher, K., 2016). Additionally, when 
assessing a patient with hypertension, it is important to identify any comorbidities. Comorbidities 
such as obesity, diabetes, dyslipidemia, and renal failure are common in patients with 
hypertension and can impact the personalized nutrition intervention (Nelms & Sucher, 2016). 
When gathering the patients past medical history, the RDN should also enquire a list of the 
patient’s current medications. Medications are often used with lifestyle modifications to control 
hypertension and they many antihypertensive medications have possible food drug interactions 
(Nelms & Sucher, 2016).  
Patient X is a 52-year-old male who was diagnosed with hypertension when he was 13 
years old. The patient’s family history includes a mom and sister with hypertension, indicating a 
potential genetic factor relating to his hypertension. The patient has a history of obesity, and type 
II diabetes. He is married with five children. Currently the patient is getting around six hours of 
sleep at night and has no history of sleep apnea. Patient X has worked at a high stress job for 25 
years. Recently the patient has gotten a new job which he has described as more stressful than his 
previous one, indicating that chronic stress could also contribute to the patient’s hypertension. 
His job also includes traveling to various places across the United States, but over the past 25 
years has been able to decrease the amount of time he is traveling. Currently, the patient travels 
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about twice a month for periods ranging from three to five days a week. This lifestyle is 
significant when planning and implementing a nutrition intervention. Large amounts of traveling 
indicate that the patient must eat out or eat in a hotel room frequently. A nutrition intervention 
should be modified to work with the patient’s lifestyle. Patient X does not smoke or use 
smokeless tobacco. He currently takes medication to control his hypertension and diabetes. A 
current list of the patient’s medications includes, low does Aspirin, Losartan Potassium, 
Glipizide, Metformin HCL ER, and Simvastatin. Patient’s taking Losartan Potassium may have 
increased serum potassium levels and should avoid salt substitutes (Nelms & Sucher, 2016). 
Patient X states that being diagnosed with hypertension has had a limited impact on his life, 
besides having to take additional medication. This is very common in patients with hypertension; 
therefore, hypertension is often referred to as the silent killer.  
Anthropometric data 
 Anthropometrics data is imperative to any nutrition assessment and includes weight, 
height, body mass index, percent usual body weight, and recent weight changes (Nelms & 
Sucher, 2016). Anthropometric data helps RDNs identify clients who are nutritionally at risk 
(Nelms & Sucher, 2016). It is common for patients diagnosed with hypertension to be 
overweight or obese. When hypertension is present in such patients, additional increased weight 
will also cause an increase in blood pressure (US Department of Health and Human Services, 
2003). Weight loss is advised for patients with hypertension who are obese, meaning a BMI of 
30 or greater or patients who are overweight, meaning a BMI of 25-29, if they have two or more 
risk factors for heart disease (US Department of Health and Human Services, 2003). Weight loss 
can reduce systolic blood pressure by 5 to 20 mmHg per ten kilograms of body weight (Nelms & 
Sucher, 2016). Thus, even a small reduction in weight can have a large impact on managing 
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hypertension. When assessing a patient who has hypertension anthropometric data aids the RDN 
in assessing if a patient is overweight or obese.  
Patient X is currently 6’1” and weighs 263 pounds. He is obese indicated by a BMI of 35 
and a waist circumference of 42 inches. It is important to note that patient X has a large muscle 
tone especially in his legs and arms and in the past few years, patient X has had a planned weight 
loss of 95 pounds totaling a 26% weight change. The patient reported this weight change did not 
impact his blood pressure. The accuracy of this statement is questioned and additional 
information such as past blood pressure measurements. Patient X has an ideal body weight of 
184 pounds, which means an additional weight loss may aid patient X in getting his blood 
pressure under control.  
Biochemical data 
Biochemical lab results are used by the RDN to determine nutritional markers and organ 
function (Nelms & Sucher, 2016). An RDN should carefully evaluate biochemical lab values 
because many different factors influence nutritional markers. Nutritional markers and organ 
function can be influenced by food and fluid intake, certain medications, diseases, and organ 
malfunction (Nelms & Sucher, 2016). It can be determined by many different tests including, but 
not limited to, samples of blood, urine, feces, and tissues (Nelms & Sucher, 2016). Biochemical 
data is used in assessments for patients with hypertension to indicate causes that are contributing 
to the patient’s hypertension and to monitor organ function (AHA, 2017). Additionally, patients 
with hypertension have an increased risk to various comorbidities such as cardiovascular disease, 
chronic kidney disease, and diabetes (Mayo Clinic, 2020). Due to this increased risk, 
biochemical lab values that may indicate additional high-risk comorbidities are standard during 
an assessment for hypertension.  
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For a patient with hypertension, the primary measurement that should be assessed by the 
RDN is the patient’s blood pressure. This indicates to the RDN the severity of the patient’s 
hypertension. Additional biochemical labs that should be assessed are lab values that indicate 
diabetes, such as hemoglobin A1C and blood glucose levels (AHA, 2017). A fasting glucose 
greater than 126mg/dL and a hemoglobin A1C greater than 6.5% indicate the presence of 
diabetes (Nelms & Sucher, 2016). Abnormalities of lipid serum panel indicate increased risk for 
cardiovascular disease (Nelms & Sucher, 2016). Optimal lipid serum levels include total 
cholesterol less than 199mg/dL, HDL cholesterol levels between 40mg/dL and 59mg/dL, LDL 
cholesterol levels less then 100mg/dL for individuals at high risk for heart disease, and 
triglyceride levels less than 150mg/dL (Nelms & Sucher, 2016). Thyroid-stimulating hormone 
(TSH) is another basic test for patients with hypertension because hyperthyroidism and 
hypothyroidism can cause hypertension (AHA, 2017). Normal lab values for TSH range between 
0.5 to 5.0 mlU/L. Biochemical lab values related to liver and kidney function tests are standard 
for patients with cardiovascular diseases (Academy of Nutrition and Dietetics [AND], 2020). 
These tests include blood urea nitrogen (8-18mg/dL), creatinine (0.6-1.2 mg/dL), and glomerular 
filtration rate (135-200L/day) (Nelms & Sucher, 2016). Additionally, serum electrolyte lab 
values such as serum sodium (136-145mEq/L) and potassium (3.5-5.5mEq/L) should be included 
in a biochemical assessment for patients with hypertension (AND, 2020). Abnormal values for 
both serum potassium and serum sodium are not always indicators of inadequate or excessive 
intake. These values are also used to assess kidney function, hydration status, electrolyte 
imbalances and acid-base imbalances (Nelms & Sucher, 2016).  
The last time patient X checked his blood pressure it was measured at 122/86. This is an 
indication that even though the patient is on medications to help control his hypertension, he still 
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is at stage 1 of hypertension. Patient X’s last hemoglobin A1C level was 7.9%. This raises a 
concern that the patient is not in control of his diabetes and additional diabetes education should 
be considered as part of his treatment plan. Other biochemical data that should be assessed are 
the patient’s lipid profile, electrolytes such as sodium and potassium, and labs related to kidney 
and liver function.   
Nutrition focused physical finding 
 A nutrition focused physical exam is completed by an RDN to assess the patient for signs 
of malnutrition and nutrient deficiencies (Nelms & Sucher, 2016). When a RDN completes a 
nutrition focused physical exam, they look for signs of muscle wasting and subcutaneous fat loss 
(Nelms & Sucher, 2016). Additionally, during a nutrition focused physical exam, an RDN will 
assess a patient’s hair, nails, skin and eyes for signs of nutrient deficiencies and the presence of 
any edema (Nelms & Sucher, 2016). The RDN should assess the patient for abdominal obesity as 
abdominal obesity increases the risk for diabetes, metabolic syndrome, and other cardiovascular 
diseases (Nelms & Sucher, 2016). Abdominal obesity can be assessed by using waist 
circumference, which for men is equal to or greater than 40 inches for men, while 35 inches for 
women is associated with obesity and chronic disease (Nelms & Sucher, 2016). Another 
important finding during a nutrition focused physical exam is any odor related to cigarette smoke 
and/or alcohol (AND, 2020). These are indications that the patient has consumed these 
substances recently. Regarding patient X, no signs of muscle wasting, or subcutaneous fat loss 
were found. Skin, nails, hair, and eyes appeared to be within normal limits and there were no 
signs of edema present.  
Food and nutrition intake 
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 During an assessment, an RDN, gathers information related to the patient’s food and fluid 
intake, as well as physical activity (Nelms & Sucher, 2016). For patients with hypertension, the 
RDN should gather a food history (AND, 2020). Food histories can be gathered through a few 
different methods including a 24-hr recall, food frequency questionnaire, and/or a food diary 
(Nelms & Sucher, 2016). Each method of gathering information has its advantages and 
disadvantages and the RDN should choose the method that is the best fit for the patient. When 
gathering a food history from a patient with hypertension, the RDN should pay attention to 
several factors that could impact the patient’s hypertension or risk for comorbidities.  This 
includes fat and cholesterol intake, mineral intake such as sodium, potassium, calcium and 
magnesium, fiber, sterols and stanols, and omega 3-fatty acids (AND, 2020). The RDN should 
also ask the patient specific questions, such as how often they eat fruits and vegetables, whole 
grains, and legumes, and if the patient has any food allergies or intolerances (AND, 2020). 
Additionally, the RDN should gather information on lifestyle factors that may influence food 
intake such as the frequency of meals, snacks, and desserts, any recent changes in meal patterns 
or intake, how they are preparing their meals, where they are eating, and if they have ever tried 
any diets in the past (AND, 2020). The RDN should also gather information on the patient’s 
current physical activity (AND, 2020).  
Patient X stated that he tries to eat as healthy as he can. He does not add extra salt into his 
meals, however, does have a sweet tooth. For a few months, the patient was trying to follow the 
keto diet program by Sanford Profile, however, the last few weeks he has not been following it 
as closely. The patient currently eats around three meals per day and has one to three snacks a 
day. The patient eats out approximately twice a week and more often when he is traveling. His 
typical breakfast is a protein shake, protein bar, and coffee with cream and sugar. His typical 
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lunch consists of a salad with chicken or a protein shake. For dinner patient X usually eats 
whatever his wife makes. These meals are usually spaghetti, tacos, or stir fry. The patient 
typically eats something sweet after dinner and an evening snack. The patient usually has one 
glass of whiskey a week. He claims to drink around a gallon of water every day and keeps a 
water bottle at his desk while he works. When interviewing the patient, he reported that in the 
last week he ate at In-N-Out Burger, 5 Guys, and had Chinese food twice. At this time, the 
patient was traveling and due to the current COVID-19 pandemic he had to eat at fast food 
restaurants as opposed to normally dining in at restaurants while traveling. The patient is 
currently exercising twice a week, however, tries to exercise for closer to 3 to 4 times per week, 
for approximately 40 minutes to an hour-long increment. He enjoys bike rides but also runs on 
occasion. 
Comparative standards 
 Using the Mifflin St. Jeor equations with an activity factor of 1.3 the patient’s current 
estimate energy needs are 2700kcal per day (AND, 2020). Using 0.8 grams of protein per kg of 
ideal body weight the patient’s protein needs are 70 grams of protein per day and current fluid 
needs are 2700 mL per day (AND, 2020). For a patient with hypertension, the comparative 
standards for the DASH diet include less than 7% of daily fat intake from saturated fat and less 
than 2300 mg of sodium per day (Nelms & Sucher, 2016). Additionally, the daily recommended 
intakes (DRIs) for potassium, calcium and magnesium are recommended for patients with 
hypertension (Nelms & Sucher, 2016).  
 Nutrition Diagnosis  
Nutrition diagnosis is independent of the medical diagnosis. It identifies the nutrition 
related problem that the RDN will treat through nutrition interventions (Nelms & Sucher, 2016). 
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Specific nutrition diagnosis related to hypertension include excessive oral intake (NI-2.2), 
excessive mineral intake (sodium) (NI-5.10.7), overweight/obesity (NC-3.3), physical inactivity 
(NB-2.1), food and nutrition related knowledge deficit (NB-1.1) (AND, 2020). Three possible 
PES statements include:  
1.  (NI-2.2) Excessive oral intake related to loss of appetite awareness, as evidence by 
estimated intake that exceeds estimated energy needs.  
2. (NC-3.3) obesity related to excessive oral intake as evidence by a waist 
circumference more than normative for age and sex.  
3. (NI-5.10.7) Excessive sodium intake related to a food and nutrition related knowledge 
deficit concerning food sources of sodium as evidence by an estimated intake 
containing high amounts of sodium compared to the recommended daily allowance.  
Due to the information Patient X provided during the assessment, an appropriate PES 
statement for Patient X would be (NI-5.10.7) excessive sodium intake related to a food and 
nutrition related knowledge deficit concerning food sources of sodium as evidence by an 
estimated intake containing high amounts of sodium compared to the recommended daily 
allowance. 
Nutrition Intervention 
Nutrition intervention is the stage in the nutrition care process where the RDN plans to 
treat the patient’s most pressing nutrition related problem (Nelms & Sucher, 2016). The RDN 
must work with the patient, as well as other health care professionals, the patient’s family, or 
caregiver to create the best realistic treatment plan for the patient and to implement that plan into 
action (Nelms & Sucher, 2016). The four domains of the nutrition care process are food and 
nutrient delivery, nutrition education, nutrition counseling and coordination of care with other 
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health care professionals (Nelms & Sucher, 2016). Nutrition interventions for patients with 
hypertension typically focus on nutrition education, nutrition counseling and coordination of 
care. Nutrition education is used to teach patients about ways they can reduce their hypertension 
through diet and exercise (AND, 2020). Nutrition counseling is used to collaborate with the 
patient to establish goals, then implement a plan that will help the patient achieve these goals in a 
way that works for the patient (AND, 2020). Coordination of care with a mental health 
professional for stress maintenance or smoking cession may also be an important part of an 
intervention plan. Nutrition interventions for patients with hypertension should be targeted at 
initiating a diet, such as the DASH diet that emphasize: 
• A high intake of vegetables, fruits, and whole grains. 
•  Incorporating low fat dairy items, poultry, fish, legumes, vegetable oils and nuts 
into meals. 
• Limiting intake of red meats, sodium, and sweets. 
Additionally, nutrition interventions should include weekly physical activity goals and 
maintenance of a healthy weight (AND, 2020).  
The current recommendation for patients with hypertension is to follow the DASH diet 
while limiting sodium intake to 1,500-2400mg per day (AND, 2020). An intervention plan for 
Patient X should include education on the DASH diet with a sodium restriction of less than 
2,300mg per day (Lennon, et al, 2017).  Additionally, diet education about healthy eating while 
traveling should be provided to the patient. Nutrition counseling should be used to collaborate 
with Patient X to create individualized goals and a plan on how the patient will meet these goals.  
Monitoring and Evaluation 
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Monitoring and evaluating the patient’s progress is an important part of the nutrition care 
process. After the initial assessment, three follow-up appointments should be scheduled with the 
patient every other week, and then once a month for the first year (Lennon, et al, 2017). After the 
first year, appointments should be made 2-3 times per year (Lennon, et al, 2017). The RDN will 
monitor the patients progress and evaluate the success of the nutrition intervention at these 
appointments by evaluating the patient’s weight, blood pressure and food intake through a 24-
hour recall. The RDN may provide additional medical nutrition therapy techniques such as 
motivational interviewing, additional nutrition education or adjustments to the patient’s nutrition 
intervention plan if progress is not being shown.   
Conclusion/Prevention  
Hypertension is a very prevalent condition around the world. Diet and lifestyle changes 
can greatly reduce a patient’s blood pressure, as well as reduce the risk of further health 
complications associated with hypertension. Additionally, similar diet and lifestyle modifications 
can be used to prevent hypertension. These include eating a diet high in fruit, vegetables and 
whole grains and low in sodium and fat; maintaining a healthy weight; getting at least 2 hours 
and 30 minutes of physical activity per week; limiting alcohol intake and getting enough sleep 
(Center for Disease Control, 2020). The nutrition care process in important for the treatment of 
hypertension. A nutrition intervention can reduce the patient’s blood pressure, leading to 
decrease in the health risks associated with hypertension. A successful intervention can improve 
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